WHERE FUNCTIONAL EPIGENETIC CREATES FUTURE
Signal Transduction Medicine - Translating Biological Intelligence into Therapy
A FUNDAMENTAL CONVICTION:
Biology is an intelligent communication system
YENO Evolution is an innovation platform at the forefront of functional epigenetics, biosignal medicine, and signal transduction technologies, dedicated to shaping the next generation of personalized biological healthcare. More than a single technology or product, YENO represents an integrated scientific ecosystem that connects biology, epigenetics, immunology, systems medicine, regenerative sciences, and advanced biotechnology into one unified platform for understanding and advancing human health. At the heart of YENO lies a fundamental conviction: biology is an intelligent communication system. Every cell, tissue, and organ continuously exchanges information through highly coordinated signaling networks. Health emerges from coherent biological communication, while dysfunction often reflects disturbances within these regulatory architectures. This systems-based understanding forms the foundation of everything we develop. YENO enables the translation of complex biological data into meaningful biological insights. Rather than focusing exclusively on isolated molecules or individual biomarkers. " We make the language of biology visible—revealing functional networks, regulatory pathways, epigenetic programs, and communication patterns that define the behavior of living systems. The patented Quantum ONE® Technology serves as the technological core of this platform and powers a new generation of Biosignal Medicine™. Through advanced signal transduction engineering, biologically relevant information can be transformed into functional signal equivalents, opening entirely new possibilities for personalized and epigenetic regulation. Today, the YENO Platform encompasses more than 82 proprietary Biosignal Remedies® and epigenetic signaling solutions, representing one of the world's leading ecosystems for functional epigenetics and Biosignal Medicine. By transforming scientific insights into real-world applications, YENO bridges innovation, personalized biology, and the future of integrative healthcare. The YENO ecosystem combines innovative technologies, proprietary methodologies, scientific expertise, and personalized biological solutions within a single platform architecture. This enables the development of highly individualized approaches that respect the complexity, adaptability, and self-organizing intelligence of living systems. Because everything begins with a signal. And every signal carries the potential to shape the future, not only of health, but of human evolution itself.
YENO Quantum ONE Technology
-
A paradigm shift in medicine.
-
From Molecule to Signal.
-
From Standard to Precision.
The transition from chemistry to communication marks one of the most significant shifts in modern medicine. YENO Quantum One Technology stands at this intersection, bridging physics, biology, epigenetics, and precision medicine to unlock a future where cellular intelligence can be supported through the language of life itself.
Claudia. B. Klein, CEO & Founder
Functional Epigenetic via Signaltransduction
YENO QUANTUM ONE TECHNOLOGY
A new generation of Biosignal Medicine
The future of medicine is no longer defined solely by chemical substances, but by the biological information they carry. The patented YENO Quantum One Technology represents a new generation of functional and epigenetic medicine. It enables the transfer of a molecule’s biological information into its corresponding signal transduction equivalent, creating a new paradigm in precision therapeutics based on cellular communication rather than molecular mass. At the heart of this innovation lies a simple yet profound principle: It is not only the molecule itself that matters, it is the biological signal it conveys. Using a proprietary multifrequency electromagnetic photon field, the Quantum One system captures the functional characteristics of naturally occurring regulatory molecules and transforms them into pure biological information. This process enables targeted cellular signal transduction while eliminating the transfer of molecular structure itself. Cellular life is fundamentally governed by communication. Every process, from gene expression and tissue regeneration to immune function and cellular adaptation, depends on highly coordinated signaling networks. The Quantum One Technology is designed to interact with these natural communication pathways, supporting functional regulation at key biological and epigenetic positions. The underlying YENO approach focuses on the targeted transport of biological information to intracellular and intranuclear structures, where signal transduction mechanisms play a decisive role in cellular regulation and functional adaptation. Through this concept, YENO explores entirely new possibilities for precision medicine based on information, communication, and biological coherence rather than conventional pharmacological intervention. Today, Quantum One serves as the technological foundation for a growing portfolio of functional epigenetic applications in regenerative medicine, immunology, oncology, healthy aging, and cellular restoration. It embodies a vision in which medicine evolves from standardized protocols toward truly individualized biological regulation.
Signal transduction is
the fundamental language of life.
The communication network through which every cell recognizes who it is, what it needs, and where it should develop. Billions of pieces of information circulate every second in this invisible dialogue. Receptors receive impulses from the environment, ion currents open up new states, and epigenetic switches respond with precise changes in gene activity, metabolism, and regeneration. This is the basis for our thinking, feeling, healing, and growth.
Functional Epigenetic via Signaltransduction
Cellular life is fundamentally governed by communication
Biology is an intelligent communication system
YENO builds on this fundamental biological truth: cell communication determines health, resilience, energy, and the future. YENO specific signal transduction molecules, precisely selected bio-intelligent modulators, act directly on the interfaces where biology translates information. They activate repair programs, apoptosis, improve receptor sensitivity, regulate inflammation, promote cellular clarity, and thus create an environment in which the body can independently find its way back to coherence and optimal regulation. This is where science meets consciousness. Every molecule that clarifies or opens a signaling pathway also strengthens the inner capacity for perception, regeneration, and reorientation. YENO signal transduction molecules are designed to use the natural intelligence of the cell to guide it back to its true potential, coherence, order, and natural evolution. This gives rise to a new understanding of healing: not as an intervention against the body, but as the precise activation of the communication pathways that give rise to life. Where YENO signal transduction takes effect, the cell begins to speak clearly, coherently, and with a view to the future. YENO signal transduction molecules from functional epigenetics enable unique, scientifically proven access to the cell nucleus and precisely regulate key epigenetic positions. Because every signal shapes reality. And every clear signal opens up a new future.
CELL COMMUNICATION
via SIGNALTRANSDUCTION MOLEKULE
Signal transduction is the silent conductor of life. The ancient, highly intelligent communication system that connects every cell, every organ, every thought, and every impulse of consciousness. It is the language of biology and, at the same time, the invisible architecture that determines how we feel, think, regenerate, and develop. Every decision, every inner image, every experience generates signals that shape our cellular reality via receptors, ion channels, and epigenetic switches. YENO is based precisely on this universal principle: the body's ability to absorb information, interpret it, and translate it into precise biological responses. Where modern epigenetics meets consciousness research, a new understanding of health and the future emerges: we are not victims of our genes, but active designers of our signaling pathways. Thus, signal transduction becomes more than a biochemical process, it becomes a portal between inner and outer reality. It explains why intention, touch, frequency, micronutrients, breath, and emotion can have measurable effects.It shows that healing does not happen “from the outside,” but through the precise activation of those programs that are deeply embedded within us. YENO uses this insight to scientifically refine and spiritually expand transformation: We activate those intelligent patterns that enable evolution—in the cell, in the nervous system, and in consciousness. Because everything begins with a signal. And every signal can shape the future.
We believe that the future of medicine will not be defined by standardized protocols alone,
but by understanding the unique biological reality of each individual. Precision medicine therefore evolves into biological precision intelligence, where data becomes understanding, understanding becomes communication, and communication becomes personalized biological action.
Translating Biological Intelligence
into Therapeutic Innovation
YENO is the first company in the world to develop epigenetic signal transduction molecules that precisely regulate cell functions intranuclearly. Our research ranges from telomerase inhibition in HL60 cells to telomere elongation and longevity programs to calcium modulation with annexins, immune regulation through S1P phosphorylation, biophysical stem cell reprogramming, and epigenetic osteointegration.
YENO is thus ushering in a new era of functional epigenetics from cellular regeneration to clinical application. Drawing on cellular communication and the language of biology, YENO has developed 82 highly precise, customized therapeutic solutions in the form of oral and parenteral GENOS remedies.
Research & Development / the GENOS Method
Medical Customized Solutions
From Biological Data to Individual Therapeutics
YENO Evolution is an international research and development company focused on developing novel biological drugs based on signal transduction. In collaboration with hospitals, physicians, research institutions, and industry partners, we develop customized therapeutic approaches and new drug platforms based on the biological information architecture of complex diseases. At the heart of our work is our patented Quantum ONE® technology, which is protected in Europe and the U.S. and forms the basis of our Biosignal Medicine platform. Using this process, biologically relevant information from selected substances is converted into therapeutically useful signal transduction equivalents and further developed into new, personalized drugs. Modern diagnostics today provide extensive information on signaling pathways, resistance mechanisms, immunology, and cellular regulatory networks. Our mission is to translate this biological information into new therapeutic concepts. One example of this is GENOS Signal Oncology®, a method developed by YENO for personalized oncological biosignal-based drugs. Based on liquid biopsy analyses and next-generation data, individual tumor profiles are analyzed to develop patient-specific signal transduction equivalents that enable a multidimensional biological therapy architecture. This development model also serves as a blueprint for further medical applications and clinical collaborations. On-Demand Drug Development for Clinics and Institutions YENO Evolution collaborates with partner clinics and medical institutions to develop new biosignal-based drugs on demand. This process is based on: These data give rise to new therapeutic concepts that are specifically developed to meet the respective clinical requirements and can be implemented as individualized compounded medications or as part of joint research projects. Liquid biopsy and functional diagnostics Next-generation sequencing Biological network and signaling pathway analyses Clinical requirements and individualized treatment goals Epigenetic and immunological regulatory mechanisms This transforms biological diagnostics into a new form of intelligent drug development. White-Label Development In addition to its own platforms, YENO Evolution offers the development of white-label biosignal drugs for clinics, medical networks, research institutions, and international partners. Our range of services includes: This gives our partners the opportunity to implement their own medical concepts and therapeutic strategies based on state-of-the-art signal transduction technologies and to further develop them under their own brand. Development of new signal transduction-based drugs Custom formulation development Integration of functional and molecular diagnostics Scientific and biological modeling GMP-compliant manufacturing through partner facilities Joint research and innovation projects Our Vision We believe that the future of medicine will not be defined solely by standardized protocols, but by understanding the unique biological reality of each individual. Our mission is to translate biological intelligence into therapy—creating a new generation of personalized medicines based on communication, regulation, and signal transduction rather than molecular standardization alone.
“IT ALWAYS SEEMS IMPOSSIBLE, UNTIL ONE HAS DONE IT!”
With an investment volume of 15.8 billion US dollars, the largest global research areas are currently epigenetics, telomeres and cell rejuvenation (longevity).
YENO Evolution was ahead of its time and recognized this megatrend early on. For a decade now, it has covered all three research topics with its GENOS method and GENOS products. By using the unique RM31 signal transduction molecule, YENO is already positioned in all three areas with significant and unique results.
Hubertus Baumgartner Founder & CEO
